News & Updates

Alprazolam safe, effective for controlling seizures
Alprazolam safe, effective for controlling seizures
26 Nov 2022

The use of alprazolam leads to rapid termination of seizures in patients with focal and/or generalized epilepsy treated in an inpatient setting, according to the results of the phase II study ENGAGE-E-001.

Alprazolam safe, effective for controlling seizures
26 Nov 2022
Myocarditis, pericarditis not uncommon with mRNA-1273 COVID-19 vaccines
Myocarditis, pericarditis not uncommon with mRNA-1273 COVID-19 vaccines
26 Nov 2022

Although the incidence of myocarditis or pericarditis following mRNA COVID-19 vaccination is low, a two- to threefold higher likelihood is seen among individuals who received mRNA-1273 compared to BNT162b2 vaccine, reveals a study.

Myocarditis, pericarditis not uncommon with mRNA-1273 COVID-19 vaccines
26 Nov 2022
Lower all-cause death, fewer HF events with empagliflozin in acute HF
Lower all-cause death, fewer HF events with empagliflozin in acute HF
25 Nov 2022 byRoshini Claire Anthony

Patients hospitalized with acute heart failure (HF) have a reduced risk of subsequent HF events or all-cause mortality if treated with once-daily empagliflozin while in hospital, according to results of the EMPULSE trial presented at HFSA 2022.

Lower all-cause death, fewer HF events with empagliflozin in acute HF
25 Nov 2022